HC Wainwright Issues Negative Estimate for OTLK Earnings
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 EPS estimates for shares of Outlook Therapeutics in a note issued to investors on Tuesday, February 18th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($0.60) per share for the quarter, down from their […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 EPS estimates for shares of Outlook Therapeutics in a note issued to investors on Tuesday, February 18th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($0.60) per share for the quarter, down from their […]
